These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26067173)

  • 1. Radiosynthesis and preliminary PET evaluation of glycogen synthase kinase 3β (GSK-3β) inhibitors containing [(11)C]methylsulfanyl, [(11)C]methylsulfinyl or [(11)C]methylsulfonyl groups.
    Kumata K; Yui J; Xie L; Zhang Y; Nengaki N; Fujinaga M; Yamasaki T; Shimoda Y; Zhang MR
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3230-3. PubMed ID: 26067173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of [(11)C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β).
    Cole EL; Shao X; Sherman P; Quesada C; Fawaz MV; Desmond TJ; Scott PJ
    Nucl Med Biol; 2014 Jul; 41(6):507-12. PubMed ID: 24768148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).
    Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH
    Bioorg Med Chem Lett; 2011 Jan; 21(1):245-9. PubMed ID: 21115250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies.
    Vasdev N; Garcia A; Stableford WT; Young AB; Meyer JH; Houle S; Wilson AA
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5270-3. PubMed ID: 16202587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and preliminary characterization of radioiodinated benzofuran-3-yl-(indol-3-yl)maleimide derivatives as potential SPECT imaging probes for the detection of glycogen synthase kinase-3β (GSK-3β) in the brain.
    Ono M; Kitada A; Watanabe H; Miyazaki A; Kimura H; Saji H
    J Labelled Comp Radiopharm; 2016 Jun; 59(8):317-21. PubMed ID: 27126914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of carbon-11-labeled isonicotinamides as new potential PET agents for imaging of GSK-3 enzyme in Alzheimer's disease.
    Gao M; Wang M; Zheng QH
    Bioorg Med Chem Lett; 2017 Feb; 27(4):740-743. PubMed ID: 28119025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel
    Zhong Y; Yang S; Cui J; Wang J; Li L; Chen Y; Chen J; Feng P; Huang S; Li H; Han Y; Tang G; Hu K
    Mol Pharm; 2021 Mar; 18(3):1277-1284. PubMed ID: 33492962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective synthesis of the novel chiral sulfoxide derivative as a glycogen synthase kinase 3beta inhibitor.
    Saitoh M; Kunitomo J; Kimura E; Yamano T; Itoh F; Kori M
    Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1252-4. PubMed ID: 20823611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and evaluation of 3-aryl-4-pyrrolyl-maleimides as glycogen synthase kinase-3β inhibitors.
    Ye Q; Li M; Zhou YB; Cao JY; Xu L; Li YJ; Han L; Gao JR; Hu YZ; Li J
    Arch Pharm (Weinheim); 2013 May; 346(5):349-58. PubMed ID: 23585245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and structure-activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.
    Saitoh M; Kunitomo J; Kimura E; Hayase Y; Kobayashi H; Uchiyama N; Kawamoto T; Tanaka T; Mol CD; Dougan DR; Textor GS; Snell GP; Itoh F
    Bioorg Med Chem; 2009 Mar; 17(5):2017-29. PubMed ID: 19200745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.
    Thotala DK; Hallahan DE; Yazlovitskaya EM
    Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
    Furlotti G; Alisi MA; Cazzolla N; Dragone P; Durando L; Magarò G; Mancini F; Mangano G; Ombrato R; Vitiello M; Armirotti A; Capurro V; Lanfranco M; Ottonello G; Summa M; Reggiani A
    J Med Chem; 2015 Nov; 58(22):8920-37. PubMed ID: 26486317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of [
    Jia J; Yi L; Xia Z; Yang M; Qiu D; Zhao Z; Peng Z
    Bioorg Med Chem Lett; 2023 May; 88():129263. PubMed ID: 37004924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
    Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
    Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.
    An WL; Bjorkdahl C; Liu R; Cowburn RF; Winblad B; Pei JJ
    J Neurochem; 2005 Mar; 92(5):1104-15. PubMed ID: 15715661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
    Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
    Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.